Associate Professor of Medicine, Brigham and Women's Hospital
Infectious Disease
Dr. Lindsey R. Baden, MD
|
|
Give Review
Lindsey Baden works in the field of Infectious Disease. He researched medicine at Albert Einstein College of Medicine of Yeshiva University. Lindsey Baden is a published doctor and has 89 publications published. The lastest was: 'An Avid Imitator.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- An Avid Imitator.
- Utility of in-house fluconazole disk diffusion susceptibility testing in the treatment of candidemia.
- Dissecting Polyclonal Vaccine-Induced Humoral Immunity against HIV Using Systems Serology.
- Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors.
- Diversion of HIV-1 vaccine-induced immunity by gp41-microbiota cross-reactive antibodies.
- Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals.
- Induction of HIV-1-specific mucosal immune responses following intramuscular recombinant adenovirus serotype 26 HIV-1 vaccination of humans.
- Reply to "insufficient demonstration of long-term stability of Aspergillus galactomannan".
- Phase I/II Randomized Trial of Safety and Immunogenicity of LIPO-5 Alone, ALVAC-HIV (vCP1452) Alone, and ALVAC-HIV (vCP1452) Prime/LIPO-5 Boost in Healthy, HIV-1 Uninf...
- Diagnosis and management of Enterococcus spp infections during rehabilitation of cold-stunned Kemp's ridley turtles (Lepidochelys kempii): 50 cases (2006-2012).
- Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States.
- First-in-Human Evaluation of a Hexon Chimeric Adenovirus Vector Expressing HIV-1 Env (IPCAVD 002).
- Long-term stability at -20{degrees} C of Aspergillus GM in serum and bronchoalveolar lavage specimens.
- Green herring syndrome: bacterial infection in patients with mucormycosis cavitary lung disease.
- Pneumonia in the immunocompromised host.
- Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles.
- Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipients.
- BK Virus Disease after Allogeneic Stem Cell Transplantation: A Cohort Analysis.
- Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery.
- Sequence-based discovery of Bradyrhizobium enterica in cord colitis syndrome.
- Postoperative antibacterial prophylaxis for the prevention of infectious complications associated with tube thoracostomy in patients undergoing elective general thorac...
- Development and Evaluation of a Calibrator Material for Nucleic Acid-based Assays for Diagnosing Aspergillosis.
- Infections following facial composite tissue allotransplantation--single center experience and review of the literature.
- Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled Trial.
- Characterization of humoral and cellular immune responses elicited by a recombinant adenovirus serotype 26 HIV-1 Env vaccine in healthy adults (IPCAVD 001).
- First-in-human evaluation of the safety and immunogenicity of a recombinant adenovirus serotype 26 HIV-1 Env vaccine (IPCAVD 001).
- Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses.
- Cytomegalovirus disease in lung transplantation: impact of recipient seropositivity and duration of antiviral prophylaxis.
- Cord-blood hematopoietic stem cell transplant confers an increased risk for human herpesvirus-6-associated acute limbic encephalitis: a cohort analysis.
- Current issues in vaccines for adult patients with hematologic malignancies.
- Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients.
- A Targeted Peritransplant Antifungal Strategy for the Prevention of Invasive Fungal Disease after Lung Transplantation: A Sequential Cohort Analysis.
- Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study.
- Serum Galactomannan and (1->3) ?-D-Glucan Assays in Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia.
- Cord colitis syndrome in cord-blood stem-cell transplantation.
- Mortality in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients with Mucormycosis 2001-2009.
- Candida albicans cervical lymphadenitis in patients who have acute myeloid leukemia.
- International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populations.
- Molecular Methods to Improve the Diagnosis and Identification of Mucormycosis.
- Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients.
- Infectious complications associated with immunomodulating biologic agents.
- Invasive fungal disease after remote inoculation in transplant recipients.
- Invasive fungal disease in patients treated for newly diagnosed acute leukemia.
- Safety and immunogenicity of modified vaccinia Ankara (ACAM3000): effect of dose and route of administration.
- Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax.
- Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis.
- Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential...
- Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization.
- Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease.
- Case records of the Massachusetts General Hospital. Case 35-2009. A 60-year-old male renal-transplant recipient with renal insufficiency, diabetic ketoacidosis, and me...
- Hepatitis B virus reactivation following allogeneic hematopoietic stem cell transplantation.
- H1N1 influenza A disease--information for health professionals.
- Clinical decisions. Management of incidental hepatitis C virus infection--polling results.
- When to start antiretroviral therapy--ready when you are?
- Clinical decisions. Management of skin and soft-tissue infection--polling results.
- Trigeminal trophic syndrome with features of oral CMV disease.
- Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatme...
- Vaccination after stem cell transplant: a review of recent developments and implications for current practice.
- Human herpesvirus 6 encephalitis.
- Infectious complications associated with immunomodulating monoclonal antibodies used in the treatment of hematologic malignancy.
- Prevention and treatment of cancer-related infections.
- Management of oral infections in cancer patients.
- Posaconazole for invasive aspergillosis?
- Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort ...
- (1->3)beta-D-glucan assay positivity in patients with Pneumocystis (carinii) jiroveci pneumonia.
- Selective lymphopenia and opportunistic infections in neuroendocrine tumor patients receiving temozolomide.
- Human papillomavirus vaccine--opportunity and challenge.
- Antibiotic prophylaxis during chemotherapy-induced neutropenia for patients with acute leukemia.
- Getting smarter--the toxicity of undertreated HIV infection.
- Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials.
- Infectious complications associated with alemtuzumab use for lymphoproliferative disorders.
- Pharmacokinetics of ganciclovir after oral valganciclovir versus intravenous ganciclovir in allogeneic stem cell transplant patients with graft-versus-host disease of ...
- Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation.
- Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
- Antibacterial prophylaxis in patients with cancer and neutropenia.
- Prophylactic antimicrobial agents and the importance of fitness.
- Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.
- Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia.
- Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants.
- The sentinel chicken revisited: the impact of West Nile virus infection on transplant patients.
- The utility of sputum induction for diagnosis of Pneumocystis pneumonia in immunocompromised patients without human immunodeficiency virus.
- Disseminated trichosporonosis caused by Trichosporon loubieri.
- Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic ...
- Case records of the Massachusetts General Hospital. Weekly Clinicopathological exercises. Case 4-2003. A 42-year-old woman with cough, fever, and abnormalities on thor...
- Fever, neutropenia, and the second law of thermodynamics.
- Improved Detection of Invasive Pulmonary Aspergillosis Arising during Leukemia Treatment Using a Panel of Host Response Proteins and Fungal Antigens.
- Current Practice of HIV Postexposure Prophylaxis Treatment for Sexual Assault Patients in an Emergency Department.
- Vaccination With Heterologous HIV-1 Envelope Sequences and Heterologous Adenovirus Vectors Increases T-Cell Responses to Conserved Regions: HVTN 083.
Schools
Albert Einstein College of Medicine of Yeshiva University
Beth Israel Hospital
Harvard University
Doctors Specialties
- Infectious Disease Medicine
- Infectious Disease
Accepted Insurances
Education
-
Beth Israel Deaconess Medical Center -
Albert Einstein College of Medicine of Yeshiva University
Hospital
-
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1326004805 | |
| NPPES Provider LastName | BADEN | |
| NPPES Provider FirstName | LINDSEY | |
| NPPES Provider ZIPCode | 02115 | |
| NPPES Provider State | MA | |
| Specialty Description | Infectious Disease | |
| Total Claim Count | 30.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1326004805 |
| Last Name Of The Provider | BADEN |
| First Name Of The Provider | LINDSEY |
| View All |
Similar Doctors
|
|
Dr. Sandra B. Nelson, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sheila F. Mitsuma, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dahlene N. Fusco, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter M. Howley, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Sonya S. Shin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Diana M. Brainard, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Athe M. Tsibris, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter C. Drobac, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raphael Dolin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anne G. Kasmar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Salvatore A. Cilmi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah J. Cotton, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Debra D. Poutsiaka, MD
This Doctor is OpenDoctor Recommended.
|